IBO Impact BioMedical, Inc.
$3.55▼ -4.83%
Healthcare
Other
Volume 12.3K
Avg Volume (10D) 18.6K
Key Metrics & Fundamentals
Market Cap
$30.33M
P/E Ratio
0.3
Div Yield
0.00%
52W Range
2.43 - 10.51
% vs 50 MA
-32.76%
% vs 200 MA
-43.76%
RSI-14
39.1
MACD Histogram
+0.0500
Beta (1Y vs SPY)
-0.49
Free Cash Flow
$470,000
Gross Rev
$3,000
Gross Profit
$2,000
EBITDA
-$416,000
COGS
$1,000
Operating Exp
$704,000
Operating Income
-$702,000
EBIT
-$702,000
Pretax Income
-$700,000
Net Income
-$699,000
EPS (Diluted)
-0.01
Price & Volume History
Loading chart…
Recent News
DSS, Inc. Announces Form F-4 Filing in Connection with Impact Biomedical’s Proposed Business Combination with Zoar Limited
GlobeNewswire · Sep 16, 2026 9:25 AM ET
Impact Biomedical Inc Announces Filing of Form F-4 Registration Statement in Connection with Proposed Merger with Zoar Ltd. (f/k/a Dr. Ashley’s Limited)
GlobeNewswire · Sep 16, 2026 9:20 AM ET
CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)
GlobeNewswire · Sep 14, 2026 9:26 PM ET
Impact BioMedical to Effect 1-for-12.62 Reverse Stock Split
MT Newswires · Sep 11, 2026 4:32 PM ET
Impact BioMedical Inc (NYSE American: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Ltd. (previously Dr. Ashley’s Ltd.)
GlobeNewswire · Sep 11, 2026 4:05 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See IBO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.